| Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis R Romero, VI Sayin, SM Davidson, MR Bauer, SX Singh, SE LeBoeuf, ... Nature medicine 23 (11), 1362, 2017 | 553 | 2017 |
| Applications of the CRISPR-Cas9 system in cancer biology FJ Sánchez-Rivera, T Jacks Nature Reviews Cancer 15 (7), 387-395, 2015 | 435 | 2015 |
| Rapid modelling of cooperating genetic events in cancer through somatic genome editing FJ Sánchez-Rivera, T Papagiannakopoulos, R Romero, T Tammela, ... Nature 516 (7531), 428-431, 2014 | 431 | 2014 |
| Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma PK Mazur, A Herner, SS Mello, M Wirth, S Hausmann, FJ Sánchez-Rivera, ... Nature medicine 21 (10), 1163-1171, 2015 | 380 | 2015 |
| Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks WM Schneider, JM Luna, HH Hoffmann, FJ Sánchez-Rivera, AA Leal, ... Cell 184 (1), 120-132. e14, 2021 | 335 | 2021 |
| Optimized base editors enable efficient editing in cells, organoids and mice MP Zafra, EM Schatoff, A Katti, M Foronda, M Breinig, AY Schweitzer, ... Nature biotechnology 36 (9), 888-893, 2018 | 326 | 2018 |
| In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis J Roper, T Tammela, NM Cetinbas, A Akkad, A Roghanian, S Rickelt, ... Nature Biotechnology 35 (6), 569-576, 2017 | 322 | 2017 |
| A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma T Tammela, FJ Sanchez-Rivera, NM Cetinbas, K Wu, NS Joshi, ... Nature 545 (7654), 355-359, 2017 | 321 | 2017 |
| Stage-specific sensitivity to p53 restoration during lung cancer progression DM Feldser, KK Kostova, MM Winslow, SE Taylor, C Cashman, ... Nature 468 (7323), 572-575, 2010 | 312 | 2010 |
| NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination M Ruscetti, J Leibold, MJ Bott, M Fennell, A Kulick, NR Salgado, CC Chen, ... Science 362 (6421), 1416-1422, 2018 | 305 | 2018 |
| Alpha-ketoglutarate links p53 to cell fate during tumor suppression JPM IV, JJ Yashinskie, R Koche, R Chandwani, S Tian, CC Chen, ... Nature 573 (7775), 595-599, 2019 | 232 | 2019 |
| Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors HH Hoffmann, FJ Sánchez-Rivera, WM Schneider, JM Luna, ... Cell host & microbe 29 (2), 267-280. e5, 2021 | 151 | 2021 |
| Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival V Gocheva, A Naba, A Bhutkar, T Guardia, KM Miller, CMC Li, TL Dayton, ... Proceedings of the National Academy of Sciences 114 (28), E5625-E5634, 2017 | 134 | 2017 |
| An autoimmune stem-like CD8 T cell population drives type 1 diabetes SV Gearty, F Dündar, P Zumbo, G Espinosa-Carrasco, M Shakiba, ... Nature 602 (7895), 156-161, 2022 | 126 | 2022 |
| TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion M Shakiba, P Zumbo, G Espinosa-Carrasco, L Menocal, F Dündar, ... Journal of Experimental Medicine 219 (2), e20201966, 2021 | 95 | 2021 |
| SOAT1 promotes mevalonate pathway dependency in pancreatic cancer TE Oni, G Biffi, LA Baker, Y Hao, C Tonelli, TDD Somerville, A Deschênes, ... Journal of Experimental Medicine 217 (9), e20192389, 2020 | 81 | 2020 |
| A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1 E Loizou, A Banito, G Livshits, YJ Ho, RP Koche, FJ Sánchez-Rivera, ... Cancer discovery 9 (7), 962-979, 2019 | 71 | 2019 |
| Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung CP Concepcion, S Ma, LM LaFave, A Bhutkar, M Liu, LP DeAngelo, ... Cancer Discovery 12 (2), 562-585, 2022 | 65 | 2022 |
| Replication and single-cycle delivery of SARS-CoV-2 replicons I Ricardo-Lax, JM Luna, TTN Thao, J Le Pen, Y Yu, HH Hoffmann, ... Science 374 (6571), 1099-1106, 2021 | 61 | 2021 |
| Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression S Yuan, R Natesan, FJ Sanchez-Rivera, J Li, NV Bhanu, T Yamazoe, ... Cancer discovery 10 (6), 854-871, 2020 | 61 | 2020 |
Tyler Jacks在 breakthroughcancer.org 的电子邮件经过验证
